To access this element change to forms mode OFF
Grant Award View - GA135-V1
Allogeneic Stem Cell CancerImmunotherapies
GA ID:
GA135-V1
Agency:
Department of Industry, Science and Resources
Approval Date:
4-Dec-2017
Variation Publish Date:
9-Jan-2020
Variation Date:
9-Jan-2020
Category:
Industry Innovation
Grant Term:
31-Jan-2018 to 30-Oct-2021
Value (AUD):
$3,285,700.00
(GST inclusive where applicable)
Varies:
GA135
- Allogeneic Stem Cell CancerImmunotherapies
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DISR 21/22 Investing in science, technology and commercialisation
Grant Program:
Cooperative Research Centres Programme
Grant Activity:
Allogeneic Stem Cell CancerImmunotherapies
Purpose:
This CRC-P will develop "off-the-shelf" immunotherapy products for cancer. As few as 3 rare triple HLA homozygous donor cells are histocompatible with a large percentage (~50%) of the Australian population. These will be used to create haplotype induced pluripotent stem cells (iPSCs) that can be infinitely expanded. These iPSCs will be gene edited and differentiated to become cytotoxic T cells with multiple targeting receptors for use in clinical trials of relapsed ovarian and gastric cancers.
GO ID:
GO Title:
Cooperative Research Centre Projects (CRC-P) Grants
Internal Reference ID:
CRC-P60867
Selection Process:
Open Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
CARTHERICS PTY. LTD.
Recipient ABN:
51 602 297 807
Grant Recipient Location
Suburb:
CARLTON
Town/City:
CARLTON
Postcode:
3053
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
3168
Country:
AUSTRALIA